You are here: Industry Insights > MHLW

News List

Sun Pharma receives Japan MHLW approval of ILUMYATM for the treatment of Plaque Psoriasis expresspharma
June 30, 2020
ILUMYA is one of the key specialty products of Sun Pharma and it was approved by US FDA in March 2018 while the European Commission approved it in September 2018.
Japanese regulator approves Gilead’s remdesivir to treat Covid-19 pharmaceutical-technology
May 11, 2020
Gilead Sciences has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for its antiviral drug remdesivir, under the brand name Veklury, to treat Covid-19 infection.
HIV treatment Dovato (dolutegravir/lamivudine) approved in Japan europeanpharmaceuticalreview
January 16, 2020
The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted marketing approval for Dovato, a treatment for HIV-1 infection.
Orion and Bayer seek marketing clearance for darolutamide in Japan pharmaceutical-technology
March 06, 2019
Orion and Bayer have submitted an application to the Japanese Ministry of Health, Labor and Welfare (MHLW) seeking marketing authorisation for darolutamide to be applied in the treatment castration-resistant prostate cancer (CRPC).
AbbVie’s Maviret receives Japanese MHLW approval to treat HCV pharmaceufical-technology
September 29, 2017
The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved AbbVie’s Maviret (glecaprevir / pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) infection across genotypes 1 to 6 (GT1-6).
Japan MHLW approves Medtronic’s latest device biospectrumasia
September 13, 2017
IN.PACT Admiral is a clinically proven endovascular therapy that features physical dilatation of the vessel lumen by plain balloon angioplasty.
Japan MHLW grants marketing approval pharmaasia
July 18, 2017
Japan Ministry of Health, Labor and Welfare (MHLW) grants marketing approval for Olumiant (baricitinib) for the Treatment of Rheumatoid Arthritis.

Previous page 1 2 Next page